Our Perspective

• 

  Group Medical EOI - U.S. Benchmarking Survey Identifies Underwriting Challenges

  By Joe Iannetti |February 11, 2020|English

  In the fourth quarter of 2019, Gen Re released the results of our Group Medical Evidence of Insurability Underwriting Survey. The survey focused on how companies staff for and process their Evidence of Insurability (EOI) applications; it included Group...

  Read More
• 

  February 10 is National Umbrella Day - Are You Covered?

  By Maria Slowinski |February 10, 2020|English

  Business owners strive to make the best decisions for their organization. But in today’s litigious climate, even the most successful proprietors can underestimate the value and protection that a Commercial Umbrella policy provides. Everyday occurrences...

  Read More
• 

  World Cancer Day - Celebrating a Decline in U.S. Cancer Mortality

  By Jean-Marc Fix |February 04, 2020|English

  When the Cancer Statistics, 2020 report was released a few weeks ago, the press rightfully basked in the great news: In the U.S. there were 2.9 million fewer cancer deaths than there would have been if the historically increasing cancer rates had remained...

  Read More
• 

  Another Coronavirus Outbreak - What Should Insurers Do?

  By Ross Campbell |January 28, 2020|English

  The news of an outbreak in China of a new type of coronavirus (2019-nCoV), leading to respiratory illness, recalls previous potential pandemic infections. Coronavirus was behind SARS (Severe Acute Respiratory Syndrome) in 2002 and MERS (Middle East...

  Read More
• 

  Autonomous Vehicles - The Murky Road Ahead for Manufacturers, Insurers and Drivers

  By Tim Fletcher |January 27, 2020|English

  As driverless cars continue to be programmed to avoid accidents, who might be spared in an accident - a young girl, a male executive or an elderly woman crossing the road? This is just one of the moral and technological challenges facing developers...

  Read More
• 

  Understanding Viral Hepatitis - What’s Relevant to Underwriting?

  By Dr. Sandra Mitic and Annika Tiedemann |January 23, 2020|English

  Prevalence, current therapies and prevention are the key themes for insurers that are reviewing their approach to applications with a history of viral hepatitis. As its name suggests, viral hepatitis is the term used to describe diffuse inflammation...

  Read More